Stockreport

Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting [Yahoo! Finance...

Pliant Therapeutics, Inc.  (PLRX) 
PDF Data highlighted in oral presentation at AACR's Clinical Trials Mini Symposium Phase 1b indication expansion trial is enrolling SOUTH SAN FRANCISCO, Calif., April 1 [Read more]